Anindya Chatterjee

Also affiliated with Loxo Oncology at Lilly (United States), Indian Institute of Technology Kanpur

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Real-World Ramucirumab and Immune Checkpoint Inhibitor Sequences in US Patients with Advanced Gastroesophageal Cancer”.

Real-World Ramucirumab and Immune Checkpoint Inhibitor Sequences in US Patients with Advanced Gastroesophageal Cancer

Future Oncology(2023)10.2217/fon-2022-0604

N/A

0.165DataRank · unranked

2 citations

Zhanglin Lin Cui, Julie K Beyrer, Elizabeth L Hadden, Anindya Chatterjee, Astra M Liepa

Patient-reported symptom burden and functioning in patients with advanced esophageal, gastroesophageal junction (GEJ), and gastric cancer undergoing chemotherapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.183

N/A

0DataRank · unranked

3 citations

Lisa M. Hess, Fang-Yu Lin, Tsun Hsuan Chen, Elizabeth M. Gonzalez, Araceli García-González +5 more